![Yona Keisari](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yona Keisari
Fondateur chez
ALPHA TAU MEDICAL LTD.
Fortune : 6 M $ au 30/06/2026
Profil
Yona Keisari is the founder of Alpha Tau Medical Ltd. since 2015, holding the title of Chief Scientific Officer.
Dr. Keisari is the founder of the Israeli Society For Cancer Research since 2013, previously serving as President from 2013 to 2015.
Dr. Keisari currently serves as Treasurer of the International Cancer Microenvironment Society since 2015.
Formerly, Dr. Keisari worked at Tel-Aviv University as a Professor from 2002 to 2015.
Education includes graduate and doctorate degrees from Tel-Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2026 | 503 489 ( 0,57% ) | 6 M $ | 30/06/2026 |
Postes actifs de Yona Keisari
| Sociétés | Poste | Début |
|---|---|---|
| ALPHA TAU MEDICAL LTD. | Fondateur | 01/11/2015 |
International Cancer Microenvironment Society
 International Cancer Microenvironment Society Real Estate DevelopmentFinance The International Cancer Microenvironment Society (ICMS) is a multidisciplinary international network of scientists focused on advancing research related to tumor-microenvironment interactions, which include tumor cells, neighboring non-tumor cells, and molecules that influence cancer development and progression. The private company is based in Tel Aviv, Israel. The society organizes regular international conferences in partnership with organizations such as the American Association of Cancer Research and publishes the journal "Cancer Microenvironment," featuring research on gene regulation, immunity, inflammation, tumor stroma, angiogenesis, cancer stem cells, metastatic niches, and therapeutic targeting. ICMS aims to develop cancer therapies that target microenvironmental factors to improve cancer treatment and management. | Treasurer | 01/01/2015 |
Anciens postes connus de Yona Keisari
| Sociétés | Poste | Fin |
|---|---|---|
Israeli Society For Cancer Research
 Israeli Society For Cancer Research Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Fondateur | 01/01/2015 |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Yona Keisari
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Tau Medical Ltd.
 Alpha Tau Medical Ltd. Medical SpecialtiesHealth Technology Specializes in research, development and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer | Health Technology |
Israeli Society For Cancer Research
Israeli Society For Cancer Research Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
International Cancer Microenvironment Society
International Cancer Microenvironment Society Real Estate DevelopmentFinance The International Cancer Microenvironment Society (ICMS) is a multidisciplinary international network of scientists focused on advancing research related to tumor-microenvironment interactions, which include tumor cells, neighboring non-tumor cells, and molecules that influence cancer development and progression. The private company is based in Tel Aviv, Israel. The society organizes regular international conferences in partnership with organizations such as the American Association of Cancer Research and publishes the journal "Cancer Microenvironment," featuring research on gene regulation, immunity, inflammation, tumor stroma, angiogenesis, cancer stem cells, metastatic niches, and therapeutic targeting. ICMS aims to develop cancer therapies that target microenvironmental factors to improve cancer treatment and management. | Finance |
